Advantages of COS-1 monkey kidney epithelial cells as packaging host for small-volume production of high-quality recombinant lentiviruses

Journal of Virological Methods

Volumn 157, Issue 1, 2009, Pages 47-54

  Smith, Shannon L ^a   Shioda, Toshi ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

COS 1; HEK293T; Lentivirus; Packaging cell

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL STRAIN COS1; CELL STRAIN HEK293; CERCOPITHECIDAE; CONTAMINATION; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LENTIVIRINAE; MONKEY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS CULTURE; VIRUS DETECTION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; CELL ADHESION; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; COS CELLS; EPITHELIAL CELLS; LENTIVIRUS; VIRUS ASSEMBLY; VIRUS REPLICATION;

CERCOPITHECUS AETHIOPS; LENTIVIRUS;

EID: 60849119249     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.12.002     Document Type: Article

References (52)

1. Azzouz M. Gene therapy for ALS: progress and prospects. Biochim. Biophys. Acta 1762 (2006) 1122-1127
2. Baekelandt V., Eggermont K., Michiels M., Nuttin B., and Debyser Z. Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain. Gene Ther. 10 (2003) 1933-1940
3. Blesch A. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer. Methods 33 (2004) 164-172
4. Boutros M., and Ahringer J. The art and design of genetic screens: RNA interference. Nat. Rev. Genet. 9 (2008) 554-566
5. Burns J.C., Friedmann T., Driever W., Burrascano M., and Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8033-8037
6. Chang L.J., and Zaiss A.K. Lentiviral vectors. Preparation and use. Methods Mol. Med. 69 (2002) 303-318
7. Chapman S.C., Lawson A., Macarthur W.C., Wiese R.J., Loechel R.H., Burgos-Trinidad M., Wakefield J.K., Ramabhadran R., Mauch T.J., and Schoenwolf G.C. Ubiquitous GFP expression in transgenic chickens using a lentiviral vector. Development 132 (2005) 935-940
8. Charrier S., Stockholm D., Seye K., Opolon P., Taveau M., Gross D.A., Bucher-Laurent S., Delenda C., Vainchenker W., Danos O., and Galy A. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther. 12 (2005) 597-606
9. Cockrell A.S., and Kafri T. Gene delivery by lentivirus vectors. Mol. Biotechnol. 36 (2007) 184-204
10. Coleman J.E., Huentelman M.J., Kasparov S., Metcalfe B.L., Paton J.F., Katovich M.J., Semple-Rowland S.L., and Raizada M.K. Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo. Physiol. Genomics 12 (2003) 221-228
11. Cronin J., Zhang X.Y., and Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5 (2005) 387-398
12. Dann C.T. New technology for an old favorite: lentiviral transgenesis and RNAi in rats. Transgenic Res. 16 (2007) 571-580
13. Devitt G., Thomas M., Klibanov A.M., Pfeiffer T., and Bosch V. Optimized protocol for the large scale production of HIV pseudovirions by transient transfection of HEK293T cells with linear fully deacylated polyethylenimine. J. Virol. Methods 146 (2007) 298-304
14. Echeverri C.J., Beachy P.A., Baum B., Boutros M., Buchholz F., Chanda S.K., Downward J., Ellenberg J., Fraser A.G., Hacohen N., Hahn W.C., Jackson A.L., Kiger A., Linsley P.S., Lum L., Ma Y., Mathey-Prevot B., Root D.E., Sabatini D.M., Taipale J., Perrimon N., and Bernards R. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat. Methods 3 (2006) 777-779
15. Follenzi A., Santambrogio L., and Annoni A. Immune responses to lentiviral vectors. Curr. Gene Ther. 7 (2007) 306-315
16. Galy A., Roncarolo M.G., and Thrasher A.J. Development of lentiviral gene therapy for Wiskott Aldrich syndrome. Expert Opin. Biol. Ther. 8 (2008) 181-190
17. Geraerts M., Michiels M., Baekelandt V., Debyser Z., and Gijsbers R. Upscaling of lentiviral vector production by tangential flow filtration. J. Gene Med. 7 (2005) 1299-1310
18. Kafri T., van Praag H., Ouyang L., Gage F.H., and Verma I.M. A packaging cell line for lentivirus vectors. J. Virol. 73 (1999) 576-584
19. Kahl C.A., Marsh J., Fyffe J., Sanders D.A., and Cornetta K. Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus. J. Virol. 78 (2004) 1421-1430
20. Koblinski J.E., Wu M., Demeler B., Jacob K., and Kleinman H.K. Matrix cell adhesion activation by non-adhesion proteins. J. Cell Sci. 118 (2005) 2965-2974
21. Koldej R., Cmielewski P., Stocker A., Parsons D.W., and Anson D.S. Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production. J. Gene Med. 7 (2005) 1390-1399
22. Kolegraff K., Bostik P., and Ansari A.A. Characterization and role of lentivirus-associated host proteins. Exp. Biol. Med. (Maywood) 231 (2006) 252-263
23. Lillico S.G., Sherman A., McGrew M.J., Robertson C.D., Smith J., Haslam C., Barnard P., Radcliffe P.A., Mitrophanous K.A., Elliot E.A., and Sang H.M. Oviduct-specific expression of two therapeutic proteins in transgenic hens. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 1771-1776
24. Lyon A.R., Sato M., Hajjar R.J., Samulski R.J., and Harding S.E. Gene therapy: targeting the myocardium. Heart 94 (2008) 89-99
25. Mandel R.J., Burger C., and Snyder R.O. Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production. Exp. Neurol. 209 (2008) 58-71
26. McGrew M.J., Sherman A., Ellard F.M., Lillico S.G., Gilhooley H.J., Kingsman A.J., Mitrophanous K.A., and Sang H. Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep. 5 (2004) 728-733
27. Mitta B., Rimann M., and Fussenegger M. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles. Metab. Eng. 7 (2005) 426-436
28. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., Carpenter A.E., Foo S.Y., Stewart S.A., Stockwell B.R., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M., and Root D.E. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124 (2006) 1283-1298
29. Moffat J., and Sabatini D.M. Building mammalian signalling pathways with RNAi screens. Nat. Rev. Mol. Cell Biol. 7 (2006) 177-187
30. Mortellaro A., Hernandez R.J., Guerrini M.M., Carlucci F., Tabucchi A., Ponzoni M., Sanvito F., Doglioni C., Di Serio C., Biasco L., Follenzi A., Naldini L., Bordignon C., Roncarolo M.G., and Aiuti A. Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects. Blood 108 (2006) 2979-2988
31. Myers R.M., and Tjian R. Construction and analysis of simian virus 40 origins defective in tumor antigen binding and DNA replication. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 6491-6495
32. Naldini L., Blomer U., Gage F.H., Trono D., and Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11382-11388
33. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
34. Neschadim A., McCart J.A., Keating A., and Medin J.A. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 13 (2007) 1407-1416
35. Nixon A.J., Goodrich L.R., Scimeca M.S., Witte T.H., Schnabel L.V., Watts A.E., and Robbins P.D. Gene therapy in musculoskeletal repair. Ann. N.Y. Acad. Sci. 1117 (2007) 310-327
36. Paddison P.J., Silva J.M., Conklin D.S., Schlabach M., Li M., Aruleba S., Balija V., O'Shaughnessy A., Gnoj L., Scobie K., Chang K., Westbrook T., Cleary M., Sachidanandam R., McCombie W.R., Elledge S.J., and Hannon G.J. A resource for large-scale RNA-interference-based screens in mammals. Nature 428 (2004) 427-431
37. Park F. Lentiviral vectors: are they the future of animal transgenesis?. Physiol. Genomics 31 (2007) 159-173
38. Root D.E., Hacohen N., Hahn W.C., Lander E.S., and Sabatini D.M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat. Methods 3 (2006) 715-719
39. Scherr M., Battmer K., Eder M., Schule S., Hohenberg H., Ganser A., Grez M., and Blomer U. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography. Gene Ther. 9 (2002) 1708-1714
40. Scott B.B., and Lois C. Generation of transgenic birds with replication-deficient lentiviruses. Nat. Protocol 1 (2006) 1406-1411
41. Segura M.M., Garnier A., Durocher Y., Coelho H., and Kamen A. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol. Bioeng. 98 (2007) 789-799
42. Segura M.M., Kamen A., and Garnier A. Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnol. Adv. 24 (2006) 321-337
43. Sena-Esteves M., Tebbets J.C., Steffens S., Crombleholme T., and Flake A.W. Optimized large-scale production of high titer lentivirus vector pseudotypes. J. Virol. Methods 122 (2004) 131-139
44. Shioda T., Andriole S., Yahata T., and Isselbacher K.J. A green fluorescent protein-reporter mammalian two-hybrid system with extrachromosomal maintenance of a prey expression plasmid: application to interaction screening. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5220-5224
45. Silva J.M., Li M.Z., Chang K., Ge W., Golding M.C., Rickles R.J., Siolas D., Hu G., Paddison P.J., Schlabach M.R., Sheth N., Bradshaw J., Burchard J., Kulkarni A., Cavet G., Sachidanandam R., McCombie W.R., Cleary M.A., Elledge S.J., and Hannon G.J. Second-generation shRNA libraries covering the mouse and human genomes. Nat. Genet. 37 (2005) 1281-1288
46. Tonini T., Claudio P.P., Giordano A., and Romano G. Transient production of retroviral- and lentiviral-based vectors for the transduction of Mammalian cells. Methods Mol. Biol. 285 (2004) 141-148
47. White S.M., Renda M., Nam N.Y., Klimatcheva E., Zhu Y., Fisk J., Halterman M., Rimel B.J., Federoff H., Pandya S., Rosenblatt J.D., and Planelles V. Lentivirus vectors using human and simian immunodeficiency virus elements. J. Virol. 73 (1999) 2832-2840
48. Yamada K., McCarty D.M., Madden V.J., and Walsh C.E. Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer. Biotechniques 34 (2003) 1074-1078 1080
49. Yamamoto T., and Tsunetsugu-Yokota Y. Prospects for the therapeutic application of lentivirus-based gene therapy to HIV-1 infection. Curr. Gene Ther. 8 (2008) 1-8
50. Zaia J.A. The status of gene vectors for the treatment of diabetes. Cell Biochem. Biophys. 48 (2007) 183-190
51. Zufferey R., Dull T., Mandel R.J., Bukovsky A., Quiroz D., Naldini L., and Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72 (1998) 9873-9880
52. Zufferey R., Nagy D., Mandel R.J., Naldini L., and Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15 (1997) 871-875